Companies Prolaio

Prolaio

Chicago

82 Total Employees

Year Founded: 2022

View Website

We're Hiring!

Data & Analytics 2 Engineering 2 Operations & Support 2 Cybersecurity 1

View all jobs

Prolaio Company Growth, Stability & Outlook in Chicago

Updated on September 09, 2026

What's the stability & growth outlook for Prolaio?

The Chicago presence is characterized by visible recruiting on Built In Chicago and connection to a product‑driven platform advancing through regulatory milestones and post‑acquisition expansion. Together, these dynamics suggest the Chicago location offers a growth‑oriented environment with strong backing and opportunities tied to innovation.

Key Insight for Candidates

Chicago’s team is actively expanding post‑acquisition, with ongoing hiring and recent employer awards—clear signals of stable, resourced growth. This matters because FDA‑cleared products and integration into a larger heart‑health platform provide momentum and runway for local projects and careers.

Evidence in Action

Year-in-review growth updates — The 2025 year-in-review reported 32 new hires, an expanded internship program, and a dedicated production operations suite. This transparent progress update helps Chicago employees see momentum, role opportunities, and near-term scaling priorities.
Quality system certifications — ISO 13485:2016 and MDSAP certifications were achieved in 2025. These validated quality systems increase process stability for Chicago teams, clarifying procedures and supporting consistent delivery as products and trials scale.

Positive Themes About Prolaio

Strong Hiring & Retention: Hiring in Chicago appears active, with a company profile on Built In Chicago featuring current job postings and sustained employer‑brand activity. These signals point to ongoing local team expansion aligned with broader growth.
Innovation-Driven Growth: The Chicago team operates within an organization advancing its platform through recent FDA clearance and expanded scope following the 2025 acquisition by Kardigan. This context suggests local work is closely tied to ongoing product and clinical‑data innovation.
Investor Backing & Capital Strength: Chicago employees are part of a business backed by a larger heart‑health parent after the 2025 acquisition, indicating increased resources to scale. This structure provides the local team with support to execute and grow.